Journals / Ankara Medical Journal / 2022 / Cilt: 22 - Sayı: 1

DETERMINATION OF PHYSICAL ACTIVITY LEVELS OF PATIENTS WITH DIABETES MELLITUS AND EVALUATION OF ITS RELATIONSHIP WITH TREATMENT COMPLIANCE

Pages
24–36
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, it has been observed that the results obtained with GPPAQ, a new measurement tool that can be easily applied in primary care, are also instructive.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Physical activity is a crucial component of the treatment of Diabetes Mellitus (DM).
📊
Key Findings & Data:Sociodemographic data, anthropometric measurements, fasting blood glucose, and HbA1C levels were recorded.
💡
Conclusion & Impact:However, it has been observed that the results obtained with GPPAQ, a new measurement tool that can be easily applied in primary care, are also instructive.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Physical activity is a crucial component of the treatment of Diabetes Mellitus (DM). This study aimed to determine the physical activity levels of patients with DM and evaluate the relationship between their adherence to treatment. Materials and Methods: The study was designed as a single-center, prospective, analytical study. It was conducted with patients who applied to the Family Medicine Outpatient Clinic for any reason, those who had a diagnosis of DM for at least one year. Sociodemographic data, anthropometric measurements, fasting blood glucose, and HbA1C levels were recorded. Physical activity levels were assessed using the General Practice Physical Activity Questionnaire (GPPAQ) and the International Physical Activity Questionnaire (IPAQ). The levels of compliance with drug treatment were assessed using the Modified Morisky Medication Adherence Scale-8 (MMMAS-8). Results: The mean age of 237 people included in the study was 51.32 ± 8.62 years (25-65), and most were women (n=141; 59.49%). The majority of the participants were physically inactive. (according to IPAQ n=143, 60.34%; GPPAQ n=161, 67.93%). 55.70% (n=132) had a moderate-high level of treatment compliance. No statistically significant correlation was determined between both scales measuring physical activity level and compliance of individuals to drug treatment (p=0.110 for GPPAQ; p=0.714 for IPAQ). Conclusion: No significant correlation was found between the physical activity levels of patients with DM and their compliance with drug therapy. However, it has been observed that the results obtained with GPPAQ, a new measurement tool that can be easily applied in primary care, are also instructive.

🔖

Cite This Article

BASAT, O., KARAMAN, S. T., OKUR, H. (2022). DETERMINATION OF PHYSICAL ACTIVITY LEVELS OF PATIENTS WITH DIABETES MELLITUS AND EVALUATION OF ITS RELATIONSHIP WITH TREATMENT COMPLIANCE. Ankara Medical Journal, Cilt: 22 - Sayı: 1, 24–36. https://ajindex.com/articles/441685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi Ve İzlem Kılavuzu-2020 [Internet]. https://temd.org.tr/admin/uploads/tbl_kilavuz/20200625154506-2020tbl_kilavuz86bf012d90.pdf (Accessed: 20.10.2021
  2. Global recommendations on physical activity for health. Geneva: WHO, 2010 [Internet]. https://www.who.int/publications/i/item/9789241599979 (Accessed:20.10.2021
  3. Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017;84(7):15-21
  4. TSBHS. Türkiye Diyabet Programı 2015-2020, Ankara. Sağlık Bakanlığı Yayınları. 2014(816):13
  5. Oliveira C, Simões M, Carvalho J, Ribeiro J. Combined exercise for people with type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2012;98(2):187-98
  6. Duarte CK, Almeida JC, Merker AJ, Brauer Fde, Rodrigues TC. Physical activity level and exercise in patients with diabetes mellitus. Rev Assoc Med Bras(English Edition). 2012;58(2): 215-21
  7. Çolak TK, Acar G, Dereli E, et al. Association between the physical activity level and the quality of life of patients with type 2 diabetes mellitus. J Phys Ther Sci. 2016;28:142–47
  8. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence:Its importance in cardiovascular outcomes. Circulation. 2009;119:3028-35
  9. Krapek K, King K, Warren SS et al. Medication adherence and associated hemoglobin A1C in type 2 diabetes. Ann Pharmacother. 2004; 38(9):1357–62 10. Rubin Richard R. Adherence to pharmacologic therapy in patients with Type 2 diabetes mellitus. Am J Med. 2005; 118 Suppl 5A:27–34
  10. Asche C, Lafleur J, Conner C. Review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics. 2011; 33:74-109
  11. Wood B. Medication adherence, the real problem when treating chronic conditions. US Pharm. 2012;37(4):3-6
  12. Tominaga Y, Aomori T, Hayakawa T, Morisky DE, Takahashi K, Mochizuki M. Relationship between medication adherence and glycemic control in Japanese patients with type 2 diabetes. Pharmazie. 2018;73(10):609-12
  13. Hammad MA, Mohamed Noor DA, Syed Sulaiman SA. The effect of patient's adherence on HBa1c control. Archives of Medical and Pharmaceutical Sciences Research (AMPSR):2017;01(01):30-5
  14. Strath SJ, Kaminsky LA, Ainsworth BE, et al. Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association. Circulation. 2013;128(20):2259-79
  15. Department of